← All organizations
Shanghai Junshi Bioscience Co.,Ltd.
For profitWebsite ↗
Also known as: Shanghai Junshi Bioscience Co., Ltd. | Shanghai Junshi Bioscience Co.,Ltd. | Shanghai Junshi Biosciencee Co.,Ltd | Shanghai Junshi Biosciences Co., LTD | Suzhou Junjing BioSciences Co., Ltd. | TopAlliance Biosciences, Inc.
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2016Last known activity
Dec 30, 2025
Timeline
2010s
- Jan 1, 2012
Shanghai Junshi Bioscience Co.,Ltd.— Founded
Drugs by trial phase (78 distinct, 139 trials)
Phase 3 (28 own, 0 via acquisition)
Phase 2 (34 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cholangiocarcinoma
- Colorectal Neoplasms
- Disease Progression
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypopharyngeal Neoplasms
- Infections
- Kidney Neoplasms
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Melanoma
- Nasopharyngeal Carcinoma
- Neoplasms
- Neoplasms, Squamous Cell
- Neuroendocrine Tumors
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Triple Negative Breast Neoplasms
- Urologic Neoplasms
Recent trials (50)
- NCT07309276Lead sponsorPhase 2Dec 30, 2025
- NCT07284134Lead sponsorPhase 3Dec 20, 2025
- NCT07045311Lead sponsorPhase 2Sep 17, 2025
- NCT07106034CollaboratorPhase 2Aug 31, 2025
- NCT07081022Lead sponsorPhase 2Aug 17, 2025
- NCT06909136Lead sponsorPhase 1/Phase 2Jul 28, 2025
- NCT06924606Lead sponsorPhase 2Jul 15, 2025
- NCT06882876CollaboratorPhase 1Jul 10, 2025
- NCT06969027Lead sponsorPhase 2Jun 19, 2025
- NCT06954467Lead sponsorPhase 2May 29, 2025
- NCT06940401Lead sponsorPhase 1/Phase 2Apr 30, 2025
- NCT06885385Lead sponsorPhase 2Apr 23, 2025
- NCT06944470Lead sponsorPhase 2Apr 20, 2025
- NCT06888830Lead sponsorPhase 1/Phase 2Apr 11, 2025
- NCT06868836Lead sponsorPhase 2Mar 28, 2025
Details
- Founded
- Shanghai, CN Jan 1, 2012
- Last known activity
- Dec 30, 2025